Successful management of atrial flutter in a newborn with verapamil

A. Casta, W. J. Wolf, C. J. Richardson, D. W. Sapire

Research output: Contribution to journalArticlepeer-review


Verapamil has become a popular antiarrhythmic drug for the acute management of supraventricular tachycardia in infants and children. A full‐erm, 1‐hour‐old infant presented with supraventricular tachycardia and hypotension that did not respond to vagal maneuvers and direct current cardioversion. After intravenous verapamil, the heart rate slowed and the underlying rhythm was atrial flutter.

Original languageEnglish (US)
Pages (from-to)597-598
Number of pages2
JournalClinical Cardiology
Issue number11
StatePublished - Nov 1985


  • infants
  • newborn
  • supraventricular tachycardia
  • verapamil

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Successful management of atrial flutter in a newborn with verapamil'. Together they form a unique fingerprint.

Cite this